Stocks › CPHI

CHINA PHARMA HOLDINGS, INC.

CPHI·NYSE·China China·USD
$0.44
-0.07 (-13.00%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CPHI
CHINA PHARMA HOLDINGS, INC. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CPHIS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CPHI by members of U.S. Congress · 1 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Dean PhillipsDean PhillipsHouse · D · MN CPHICHINA PHARMA HOLDINGS, INC. · Stock Sale
$15,001 - $50,000
Aug 13, 2021 Jul 1, 2021 Filing ↗

Whale Activity

Position changes in CPHI reported for 2026-09-30 by 14 institutional filers
Increased: 2New: 6Held: 1Closed: 5
  • Increased2
  • New6
  • Held1
  • Decreased0
  • Closed5
  • No prior filing0

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CPHI insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

9 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Li ZhilinCEO & Interim CFO · Director · 10% owner Grant / award +13.8M $0.14 $1.9M Sep 29, 2023 Form 4 ↗
Li ZhilinCEO & Interim CFO · Director · 10% owner Grant / award +1.8M $0.67 $1.2M Sep 9, 2021 Form 4 ↗
Li ZhilinCEO and interim CFO · Director · 10% owner Grant / award +2.0M $0.00 $0 Dec 23, 2020 Form 4 ↗
WAUNG FRANKChief Financial Officer Grant / award +100.0K $0.00 $0 Apr 28, 2012 Form 4 ↗
WAUNG FRANKChief Financial Officer Grant / award +100.0K $0.00 $0 Apr 28, 2012 Form 4 ↗
Li ZhilinPresident and CEO · Director · 10% owner Grant / award +50.0K $0.00 $0 May 25, 2011 Form 4 ↗
WAUNG FRANKChief Financial Officer Grant / award +25.0K $0.00 $0 May 25, 2011 Form 4 ↗
WAUNG FRANKChief Financial Officer Grant / award +6,863 $0.00 $0 Dec 13, 2010 Form 4 ↗
WAUNG FRANKChief Financial Officer Option exercise +4,052 — — Nov 15, 2010 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CPHI · SEC Form N-PORT

No mutual fund or ETF has reported CPHI in an N-PORT filing in the last seven months.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming CHINA PHARMA HOLDINGS, INC. as client

No lobbying filings found naming CHINA PHARMA HOLDINGS, INC. as the client.

Government Contracts

Federal awards to CHINA PHARMA HOLDINGS, INC. · USAspending

No federal contract awards found for CHINA PHARMA HOLDINGS, INC..

U.S. Patents

Recent USPTO applications naming CHINA PHARMA HOLDINGS, INC.

No USPTO patent applications found for CHINA PHARMA HOLDINGS, INC..

Annual Financials

From CPHI's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$4.1M$4.5M$7.0M$8.1M$9.6M
Operating income-$3.2M-$4.6M-$2.8M-$3.5M-$2.9M
Net income-$3.2M-$4.7M-$3.1M-$4.0M-$3.4M
Diluted EPS-$0.74-$2.71-$0.91-$3.78-$0.74
Operating cash flow$148K-$406K-$700K-$410K-$250K
Cash and equivalents$345K$627K$1.4M$2.0M$4.9M
Total assets$31.0M$14.9M$16.5M$17.8M$22.6M
Total liabilities$8.3M$7.1M$9.0M$13.5M$16.6M
Shareholders' equity$22.7M$7.7M$7.5M$4.3M$6.0M

As CHINA PHARMA HOLDINGS, INC. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Apr 1, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-10Reverse splitApr 15, 2025
  • 1-for-5Reverse splitMar 6, 2024
  • 1-for-10Reverse splitMar 6, 2023
  • 1-for-20Reverse splitAug 15, 2003

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 1.01, 8.01, 9.01Material agreement · Other eventsJul 22, 2026
    EDGAR ↗

About CHINA PHARMA HOLDINGS, INC.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersHAINAN PROVINCE, China
IncorporatedDE
Former namesTS ELECTRONICS INC, SOFTSTONE INC, SOFTSTONE INC /DE/